The latest update is out from TriSalus Life Sciences (TLSI).
TriSalus Life Sciences, Inc. has expanded its Board of Directors to ten members, welcoming Liselotte Hyveled as a new Class I director whose term will conclude at the 2024 annual stockholders meeting. Ms. Hyveled’s appointment comes with no undisclosed arrangements and in line with the company’s compensation policy, she will receive a $50,000 annual cash retainer plus stock options. Additionally, she’ll earn extra retainers for her roles on the Nominating and Corporate Governance Committee and the Science and Technology Committee, reinforcing the company’s governance and innovation strategies.
For detailed information about TLSI stock, go to TipRanks’ Stock Analysis page.
